Gordon Ramsay โDeclines Requests for Ozempic-Inspired โคRestaurant Menus
LONDON โ – โCelebrity chef Gordon Ramsay has reportedly refused requests to develop menus catering to individuals using โOzempic and other weight-loss drugs, stating he doesn’t want his restaurants associated with the trend. Ramsay’s stance comes as the use of medications โlike Ozempic-originally intended for โขdiabetes management-forโ weight loss continues to rise โin โpopularity,promptingโฃ debate about the culinary industry’sโ role โฃin accommodating โthe altered appetites of users.
The “Kitchen Nightmares” star recently launched his fine dining restaurant โฃBonheur in London’s Mayfair โขdistrict,overseen by Chef Matt Abรฉ.โฃ Whileโ discussing the new venture with โข The Sundayโข Times,Ramsay โrevealed he’s actively discouraging a growing number of requests for specialized menus designed for those โexperiencing reduced hunger due to Ozempic and โคsimilar drugs. “I don’tโฃ want to be associated with that,” Ramsay told the publication,addingโค that he doesn’tโฃ want to “cater to that.”
Ramsay’s comments reflect a broader discussion within the food and beverageโ industry regarding โthe potential โขimpact of these medications on dining experiences.Ozempic and similar โคdrugs work by slowing gastric emptying and suppressing appetite,leading to significantlyโข reduced food intake. This has โคprompted someโ restaurants to consider offering smaller portion sizes or altered menusโฃ to appeal to this growing customer base.
Though,ramsay’s position suggests a reluctance to normalize โคor encourage the use of these drugs,or to fundamentally alter his culinaryโ approach toโ accommodate them. He โขhas built his reputation on delivering robust, flavorfulโข dining experiences, and โappears determined to maintain that โstandard regardless โof current โhealth trends. The chef’s decision underscores a potential divide within the industry between adapting โto changing consumer needs and upholding established culinaryโ principles.